Towerview LLC grew its holdings in shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) by 27.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 436,873 shares of the company’s stock after buying an additional 94,395 shares during the quarter. […]
Towerview LLC boosted its holdings in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) by 27.6% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 436,873 shares of the company’s stock after purchasing an additional 94,395 shares during the period. Corvus Pharmaceuticals accounts for approximately 0.5% of Towerview LLC’s portfolio, making the stock its 17th […]
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Free Report) was the target of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 1,490,000 shares, an increase of 17.3% from the February 29th total of 1,270,000 shares. Based on an average daily trading volume, of 218,100 […]
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Free Report) crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $1.43 and traded as high as $1.54. Corvus Pharmaceuticals shares last traded at $1.51, with a volume of 105,012 shares traded. Analyst Ratings Changes A number […]
Corvus Pharmaceuticals (NASDAQ:CRVS – Get Free Report) is set to release its earnings data after the market closes on Tuesday, November 7th. Analysts expect Corvus Pharmaceuticals to post earnings of ($0.16) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link. Corvus Pharmaceuticals […]